Analyst Price Targets — ACRE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 2, 2026 6:21 am | Marissa Lobo | UBS | $5.50 | $4.93 | StreetInsider | UBS Resumes Ares Commercial (ACRE) at Neutral |
| February 12, 2026 11:54 am | Donald Fandetti | Wells Fargo | $5.00 | $5.57 | TheFly | Ares Commercial price target raised to $5 from $4 at Wells Fargo |
| April 16, 2025 1:12 pm | Doug Harter | UBS | $3.75 | $3.50 | TheFly | Ares Commercial price target lowered to $3.75 from $5.25 at UBS |
| September 20, 2024 4:46 am | Donald Fandetti | Wells Fargo | $7.00 | $7.81 | TheFly | Ares Commercial downgraded to Underweight from Equal Weight at Wells Fargo |
| April 25, 2022 8:46 am | — | J.P. Morgan | $16.00 | $15.58 | Benzinga | JP Morgan Maintains Neutral on Ares Commercial Real, Raises Price Target to $16 |
Latest News for ACRE
Neither a premium nor a discount is inherently "better." Trading at a premium provides an accretive growth engine, while deep discounts allow companies to deliver massive upside simply by avoiding further bad news. The Premium Engine at Work: CSWC's ability to issue equity at a premium to NAV added +$0.28 per share to book value, offsetting portfolio credit adjustments.
Ares Commercial Real Estate (NYSE: ACRE - Get Free Report) and Adamas Trust (NASDAQ: ADAM - Get Free Report) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Valuation and Earnings This table
Ares Commercial Real Estate NYSE: ACRE reported second-quarter 2026 GAAP net income of approximately $4.4 million, or $0.08 per diluted common share, while distributable earnings totaled about $6.9 million, or $0.12 per diluted common share.
Ares Commercial Real Estate Corporation (ACRE) Q2 2026 Earnings Call Transcript
Ares Commercial Real Estate (ACRE) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to a loss of $0.51 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACRE.
U.S. House Trading
No House trades found for ACRE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.